Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2016 Mar 17;8(2):43–54. doi: 10.1071/HI03043

A review of the Royal Perth Hospital Bali experience: an infection control perspective

Christopher H Heath 1,2, C Terri Orrell 3, Rosie CE Lee 4, John W Pearman 5, Cheryll McCullough 6, Keryn J Christiansen 7
PMCID: PMC7146777  PMID: 32288537

Abstract

Thirty five patients were transferred to Royal Perth Hospital (RPH) after the Bali bombings. The patients had severe burn injuries and were considered to be at high-risk of both the carriage and acquisition of multi-resistant organisms (MROs). Whilst seeking to protect the Bali patients with a comprehensive infection control response, we also sought to protect other high-risk patients from nosocomial acquisition of MROs. MROs were detected from 25 (82%) of the 29 Bali patients admitted to RPH. Bali patients were colonised, or infected, with one or more of the following MROs: multi-resistant Acinetobacter baumannii (MRAB) (19 patients), extended-spectrum ß-lactamase (ESBL) producing Gram-negative bacteria (15 patients), vancomycin-resistant enterococci (VRE) (nine patients), multi-resistant Pseudomonas aeruginosa (MRPA) (six patients), multi-resistant Chryseobacterium sp. (four patients), and methicillin-resistant Staphylococcus aureus (MRSA) (three patients). Five Bali patients developed a total of eight bacteraemic episodes, with MRPA sepsis contributing to death in two patients. Since the Bali bombings horizontal transmission of Bali MROs has occurred in 41 non-Bali patients in RPH. MRPA has had the greatest clinical impact. Eight non-Bali patients developed a total of 11 bacteraemic episodes, with MRPA sepsis contributing to death in four patients. However, apart from MRPA, we have now controlled transmission of the other MROs in RPH.

The emergency response to the Bali disaster required strong leadership, good communication and multi-disciplinary teamwork. The infection control strategy contributed to good outcomes for most Bali bombing patients. However, many patients within the Bali cohort were heavily colonised with MROs, and some developed invasive infection. Subsequent nosocomial transmission of these MROs to non-Bali patients has been a legacy of the Bali tragedy.

References

  • 1.Update: outbreak of severe acute respiratory syndrome - Worldwide, 2003. MMWR Morb Mort Wkly Rep. 2003;52:241–248. [PubMed] [Google Scholar]
  • 2.Watts J. Bali bombing offers lessons in disaster relief. Lancet. 2002;360:1401. doi: 10.1016/s0140-6736(02)11428-0. [DOI] [PubMed] [Google Scholar]
  • 3.Southwick G.J., Pethick A.J., Thalayasingam P., Vijayasekaran V.S., Hogg J.J.W. Australian doctors in Bali: the initial medical response to the Bali bombing. Med J Aust. 2002;177:624–626. doi: 10.5694/j.1326-5377.2002.tb04987.x. [DOI] [PubMed] [Google Scholar]
  • 4.Hampson G.V., Cook S.P., Frederiksen S.R. Operation Bali Assist: the Australian Defence Force response to the Bali bombing, 12 October 2002. Med J Aust. 2002;177:620–623. doi: 10.5694/j.1326-5377.2002.tb04986.x. [DOI] [PubMed] [Google Scholar]
  • 5.Fisher D., Burrow J. The Bali bombings of 12 October 2002 lessons in disaster management for physicians. Intern Med J. 2003;33:125–126. doi: 10.1046/j.1445-5994.2003.00371.x. [DOI] [PubMed] [Google Scholar]
  • 6.Vinen J. Bali: a wake up call. Intern Med J. 2003;33:71–73. doi: 10.1046/j.1445-5994.2003.00380.x. [DOI] [PubMed] [Google Scholar]
  • 7.Murray P.R., Baron E.-J., Pfaller M.A., Tenover F.C., Yolken R.H., editors. Manual of Clinical Microbiology. 7th ed. ASM Press; Washington, DC: 1999. [Google Scholar]
  • 8.Auricht E., Borgert J., Mutler, Cadwallader H., Collignon P., Cooper C. Uniform national denominator definitions for infection control clinical indicators: surgical site and health care associated blood stream infection. Aust Infect Control. 2001;6(2):47–51. [Google Scholar]
  • 9.Tenover F.C., Arbeit R., Goering R., Mickelson P., Murray B., Persing D., Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jarvis W.R., Zaza S. Investigation of outbreaks. In: Mayhall C.G., editor. Hospital Epidemiology and Infection Control. 2nd edition. Lippincott Williams & Wilkins; Baltimore: 1999. pp. 111–120. [Google Scholar]
  • 11.Amow P.M., Flaherty J.P. Non-fermentative Gram-negative bacilli. In: May hall C.G., editor. Hospital Epidemiology and Infection Control. 2nd ed. Lippincott Williams & Wilkins; Baltimore: 1999. pp. 431–451. [Google Scholar]
  • 12.Mayhall C.G. Nosocomial burn wound infections. In: Mayhall C.G., editor. Hospital Epidemiology and Infection Control. 2nd ed. Lippincott Williams & Wilkins; Baltimore: 1999. pp. 275–286. [Google Scholar]
  • 13.Heggers J.P., Hawkins H., Edgar P., Villarreal C., Herdon D.N. Treatment of infection in bums. In: Herdon D.N., editor. Total Burn Care. 2nd ed. Saunders; London: 2002. pp. 120–169. [Google Scholar]
  • 14.Bonten M.J.M., Hariharan R., Weinstein R.A. Enterobacteriaceae. In: Mayhall C.G., editor. Hospital Epidemiology and Infection Control. 2nd ed. Lippincott Williams & Wilkins; Baltimore: 1999. pp. 407–430. [Google Scholar]
  • 15.Safdar N., Maki D.G. The commonality of risk factors for nosocomial colonisation and infection with antimicrobial- resistant Staphylococcus aureus, Enterococcus, Gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med. 2002;136:834–844. doi: 10.7326/0003-4819-136-11-200206040-00013. [DOI] [PubMed] [Google Scholar]
  • 16.Anstey N.M., Currie B.J., Withnall K.M. Community-acquired Acinetobacter pneumonia in the Northern Territory of Australia. Clin Infect Dis. 1992;14:83–91. doi: 10.1093/clinids/14.1.83. [DOI] [PubMed] [Google Scholar]
  • 17.Wong T.H., Tan B.H., Ling M.L., Song C. Multi-resistant Acinetobacter baumannii on a bums unit - clinical risk factors and prognosis. Bums. 2002;28:349–357. doi: 10.1016/s0305-4179(02)00012-8. [DOI] [PubMed] [Google Scholar]
  • 18.Siau H., Yeun K.Y., Ho P.L., Wong S.S., Woo P.C. Acinetobacter bacteraemia in Hong Kong: prospective study and review. Clin Infect Dis. 1999;28:26–30. doi: 10.1086/515068. [DOI] [PubMed] [Google Scholar]
  • 19.Aarabi B. Comparative study of bacteriological contamination between primary and secondary exploration of missile head injuries. Neurosurgery. 1987;20:610–616. doi: 10.1227/00006123-198704000-00018. [DOI] [PubMed] [Google Scholar]
  • 20.Peterson K. Multi-drug resistant (MDR) Acinetobacter in the Persian Gulf. ProMED http://www.promedmail.org posted 17 April 2003.
  • 21.Lyytikäinen O., Köljalg S., Härmä M., Vuopio-Varkila J. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a bums unit: emergence of resistance to imipenem. J Hosp Infect. 1995;31:41–54. doi: 10.1016/0195-6701(95)90082-9. [DOI] [PubMed] [Google Scholar]
  • 22.Pearman J., Perry P., Lee R., Mitchell D. Restriction of third- generation cephalosporins plus infection control measures restricted outbreaks of multi-resistant Acinetobacter baumannii in an Australian Hospital. Aust Infect Control. 1999;4(2):16–24. [Google Scholar]
  • 23.Revathi G., Shannon K.P., Stapelton P.D., Jain B.K., Sr., French G.L. An outbreak of extended-spectrum E-lactamase producing Salmonella seftenberg in a bums unit. J Hosp Infect. 1998;40:295–302. doi: 10.1016/s0195-6701(98)90307-3. [DOI] [PubMed] [Google Scholar]
  • 24.Nikolic NS, Lee RCE, Heath CH & Coulter C. An outbreak of extended-spectrum ß-lactamase producing Klebsiella pneumoniae in a bums unit. Australasian Infection Control Association Annual Scientific Meeting, 12th AICA National Conference, Perth, Western Australia May 18-19 1998, Poster #3, Abstract Book page 92.
  • 25.Paterson D.L. Infection control implications of extended-spectrum ß-lactamase (ESBL) production by Klebsiellae and other Gramnegative bacteria. Aust Infect Control. 2001;6(3):72–80. [Google Scholar]
  • 26.Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34:634–640. doi: 10.1086/338782. [DOI] [PubMed] [Google Scholar]
  • 27.Knox K., Lawson W., Dean B., Holmes A. Multidisciplinary antimicrobial management and the role of the infectious diseases pharmacist - a UK perspective. J Hosp Infect. 2003;53:85–90. doi: 10.1053/jhin.2002.1350. [DOI] [PubMed] [Google Scholar]
  • 28.Morton A.P., Looke D. Charts for surveillance of antibiotic usage. Aust Infect Control. 2003;8(1):14–19. [Google Scholar]

Articles from Australian Infection Control are provided here courtesy of Elsevier

RESOURCES